Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9

Targeting the SUMO E2 Conjugating Enzyme Ubc9 Interaction for Anti-Cancer Drug Design

(2012) Xinyuan Duan et al.   Anti-Cancer Agents in Medicinal Chemistry

Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein–Barr positive epithelial cells

(2011) Mark D. Sides et al.   VIROLOGY

Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation

(2009) S. Zimnik et al.   NUCLEIC ACIDS RESEARCH

Innate link between NF-κB activity and ubiquitin-like modifiers

(2008) Valérie Lang et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

EBV Latent Membrane Protein 1 Effects on Plakoglobin, Cell Growth, and Migration

(2008) K. H.Y. Shair et al.   CANCER RESEARCH

Epstein-Barr Virus-Encoded LMP1 Regulates Epithelial Cell Motility and Invasion via the ERK-MAPK Pathway

(2008) C. W. Dawson et al.   JOURNAL OF VIROLOGY

TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1

(2008) S. Ning et al.   MOLECULAR AND CELLULAR BIOLOGY

Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and  1 and  3 integrins

(2008) G. L. Bentz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MAPK-induced Ser727phosphorylation promotes SUMOylation of STAT1

(2007) Sari Vanhatupa et al.   BIOCHEMICAL JOURNAL